Cargando…
Pericarditis tras la administración de la vacuna de ARNm BNT162b2 contra la COVID-19
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedad Española de Cardiología. Published by Elsevier España, S.L.U.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196309/ https://www.ncbi.nlm.nih.gov/pubmed/34149145 http://dx.doi.org/10.1016/j.recesp.2021.06.006 |
_version_ | 1783706659663642624 |
---|---|
author | Ramírez-García, Almudena Lozano Jiménez, Sara Darnaude Ximénez, Ignacio Gil Cacho, Alberto Aguado-Noya, Ramón Segovia Cubero, Javier |
author_facet | Ramírez-García, Almudena Lozano Jiménez, Sara Darnaude Ximénez, Ignacio Gil Cacho, Alberto Aguado-Noya, Ramón Segovia Cubero, Javier |
author_sort | Ramírez-García, Almudena |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8196309 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81963092021-06-15 Pericarditis tras la administración de la vacuna de ARNm BNT162b2 contra la COVID-19 Ramírez-García, Almudena Lozano Jiménez, Sara Darnaude Ximénez, Ignacio Gil Cacho, Alberto Aguado-Noya, Ramón Segovia Cubero, Javier Rev Esp Cardiol Carta Científica Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. 2021-12 2021-06-12 /pmc/articles/PMC8196309/ /pubmed/34149145 http://dx.doi.org/10.1016/j.recesp.2021.06.006 Text en © 2021 Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Carta Científica Ramírez-García, Almudena Lozano Jiménez, Sara Darnaude Ximénez, Ignacio Gil Cacho, Alberto Aguado-Noya, Ramón Segovia Cubero, Javier Pericarditis tras la administración de la vacuna de ARNm BNT162b2 contra la COVID-19 |
title | Pericarditis tras la administración de la vacuna de ARNm BNT162b2 contra la COVID-19 |
title_full | Pericarditis tras la administración de la vacuna de ARNm BNT162b2 contra la COVID-19 |
title_fullStr | Pericarditis tras la administración de la vacuna de ARNm BNT162b2 contra la COVID-19 |
title_full_unstemmed | Pericarditis tras la administración de la vacuna de ARNm BNT162b2 contra la COVID-19 |
title_short | Pericarditis tras la administración de la vacuna de ARNm BNT162b2 contra la COVID-19 |
title_sort | pericarditis tras la administración de la vacuna de arnm bnt162b2 contra la covid-19 |
topic | Carta Científica |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196309/ https://www.ncbi.nlm.nih.gov/pubmed/34149145 http://dx.doi.org/10.1016/j.recesp.2021.06.006 |
work_keys_str_mv | AT ramirezgarciaalmudena pericarditistraslaadministraciondelavacunadearnmbnt162b2contralacovid19 AT lozanojimenezsara pericarditistraslaadministraciondelavacunadearnmbnt162b2contralacovid19 AT darnaudeximenezignacio pericarditistraslaadministraciondelavacunadearnmbnt162b2contralacovid19 AT gilcachoalberto pericarditistraslaadministraciondelavacunadearnmbnt162b2contralacovid19 AT aguadonoyaramon pericarditistraslaadministraciondelavacunadearnmbnt162b2contralacovid19 AT segoviacuberojavier pericarditistraslaadministraciondelavacunadearnmbnt162b2contralacovid19 |